Thursday, December 18, 2025 | 04:56 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Risk-taker gets a booster dose: Meet Adar Poonawalla, CEO, Serum Institute

SII invests 90-95 per cent of its profits every year to build capacities

Adar Poonawalla, CEO, Serum Institute
premium

Adar Poonawalla, CEO, Serum Institute

Sohini Das Mumbai
In May 2020, Adar Poonawalla, 40, and AstraZeneca Chief Pascal Soriot had a video-call and negotiated a deal to make a billion doses of the Oxford-AstraZeneca Covid-19 vaccine — a deal that helped India administer 1.44 billion vaccine doses.

All told, Poonawalla’s Serum Institute of India (SII) accounted for 88 per cent of the Covid-19 jabs given in India so far, playing a significant role in the country’s economic recovery. This alone makes him Business Standard’s Newsmaker of the Year.

A Time profile on Poonawalla (who featured in the magazine’s list of 100 most influential people of 2021) read: “The